Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...

Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...

The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Nurses are administering medicine to Mpox patients at a tent in Kabare, Democratic Republic of the Congo, as the area ...

More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

In eastern Congo, mpox detection and treatment face setbacks amid a rebel offensive backed by Rwanda. Hospitals suffer from ...

The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health Emergency of ...